CLEVELAND, Feb. 5, 2018 /PRNewswire/ — Global pharmaceutical packaging demand is projected to advance 6.0% per year to $112 billion in 2021. Aging populations, rising levels of acute and chronic conditions, and new product introductions will drive demand. These and other trends are presented in Global Pharmaceutical Packaging, 12th Edition, a new study from The Freedonia Group, a Cleveland-based industry research firm.
More information about this study is here: https://www.freedoniagroup.com/industry-study/global-pharmaceutical-packaging-by-product-and-region-12th-edition-3591.htm
Prefillable syringes will post the fastest gains of any pharmaceutical container, increasing 9.0% per year through 2021. Demand will be supported by expanding applications in the administration of critical care, emergency, and self-injectable parenteral medication. Advances in biotechnology, nanotechnology, and other advanced drug delivery technologies will increase the range of pharmaceuticals adaptable to this packaging.
Western Europe will continue to make up the greatest share of pharmaceutical packaging demand. Demand is spurred by the region’s large, advanced drug-producing industry that develops new packaging systems and introduces sophisticated therapies with specialized packaging needs.
Related studies include:
About The Freedonia Group, a division of MarketResearch.com – The Freedonia Group is a leading international industrial research company publishing more than 100 studies annually. Since 1985, we have provided research to customers ranging in size from global conglomerates to one-person consulting firms. More than 90% of the industrial companies in the Fortune 500 use Freedonia Group research to help with their strategic planning. Additional Packaging studies can be purchased at www.freedoniagroup.com, www.marketresearch.com and www.profound.com.
SOURCE The Freedonia Group